Xianrui Zhao

Title: Xianrui Zhao: Innovator in Kappa Opioid Receptor Antagonism

Introduction

Xianrui Zhao is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of pharmacology, particularly in the development of kappa opioid receptor antagonists. With a total of three patents to his name, Zhao's work is paving the way for advancements in therapeutic applications.

Latest Patents

Zhao's latest patents focus on compounds that antagonize the kappa-opioid receptor (KOR). These compounds are designed to be used in various products and methods related to their synthesis and application. The patents detail compounds with specific structures, including pharmaceutically acceptable isomers, racemates, hydrates, solvates, isotopes, or salts. This innovative approach has the potential to lead to new treatments for conditions related to opioid receptors.

Career Highlights

Throughout his career, Xianrui Zhao has worked with prominent organizations such as Blackthorn Therapeutics, Inc. and The Scripps Research Institute. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Zhao has collaborated with notable colleagues, including Edward Roberts and Miguel A Guerrero. These partnerships have enhanced his research and development efforts, leading to significant advancements in his field.

Conclusion

Xianrui Zhao's innovative work in kappa opioid receptor antagonism showcases his dedication to advancing pharmacological research. His contributions are expected to have a lasting impact on the development of new therapeutic options.